NCT07480668 Aromatherapy for Mental Health Promotion in IVF Patients
| NCT ID | NCT07480668 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Federal University of Minas Gerais |
| Condition | Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2026-03-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2026-03-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The experience of infertility can cause significant emotional instability, especially for patients awaiting In Vitro Fertilization (IVF) treatment, generating anxiety, stress, and depressive symptoms. This study is a randomized clinical trial assessing the effectiveness of aromatherapy in improving mental health and quality of life in women undergoing infertility treatment. 120 participants will be randomized into three groups (Intervention, Placebo, and Control). The intervention involves the inhalation of true lavender essential oil (Lavandula angustifolia) for four weeks.
Eligibility Criteria
Inclusion Criteria: * Female gender, age over 18 years. * Diagnosis of infertility with indication for In Vitro Fertilization (IVF). * Patients on the waiting list at HC-UFMG. * Agreement not to practice other mind-body or herbal complementary therapies during the study. * DASS-21 screening score compatible with at least mild anxiety, stress, and/or depression. * No aversion to inhaling essential oil or synthetic lavender essence. Exclusion Criteria: * Severe neurological, psychiatric, or clinical disorders (e.g., schizophrenia, severe depression) that prevent participation. * Use of medications that could confound the primary outcome (e.g., sleep medications, anxiolytics, antidepressants, neuroleptics) in the 30 days prior to or during the study. * Known allergy to lavender products. * Pregnancy during the study period. * Use of essential oils in the last 90 days.
Contact & Investigator
Bárbara P Aquino, MSc
STUDY CHAIR
Federal University of Minas Gerais
Frequently Asked Questions
Who can join the NCT07480668 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07480668 currently recruiting?
Yes, NCT07480668 is actively recruiting participants. Contact the research team at rubens.ufmg@gmail.com for enrollment information.
Where is the NCT07480668 trial being conducted?
This trial is being conducted at Belo Horizonte, Brazil.
Who is sponsoring the NCT07480668 clinical trial?
NCT07480668 is sponsored by Federal University of Minas Gerais. The principal investigator is Bárbara P Aquino, MSc at Federal University of Minas Gerais. The trial plans to enroll 120 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.